What is the Share Price of Dr Lalchandani Labs Ltd?

Dr Lalchandani Labs Ltd share price is ₹12.10 As on 09 May, 2025|11:02

Home
>
Stocks
>
Dr Lalchandani Labs Ltd

Dr Lalchandani Labs Ltd Share Price

Q: What is the Market Cap of Dr Lalchandani Labs Ltd?

The Market Cap of Dr Lalchandani Labs Ltd is ₹5.09 As on 09 May, 2025|11:02

Q: What is PE Ratio of Dr Lalchandani Labs Ltd?

The P/E ratio of Dr Lalchandani Labs Ltd is 5.92 As on 09 May, 2025|11:02

Q: What is PB Ratio of Dr Lalchandani Labs Ltd?

The PB ratio of Dr Lalchandani Labs Ltd is 0.54 As on 09 May, 2025|11:02

₹ 0.00 0 (0%)
Updated on 01-01-1970 5:30 AM

Stock Rating

BSE

Pros 0

Cons 10

Dr Lalchandani Labs Ltd Price Performance

Day's Low
₹0

Day's High
₹0

₹ 0

52-w low
₹0

52-w high
₹0

Day's open
₹0
Previous close
₹0
VWAP
₹0
Lower price band
₹0
Upper price band
₹0

Today's Market Action

Its last traded stock price on BSE was 12.10 down by -3.12%. The total volume of shares on NSE and BSE combined was 12,000 shares. Its total combined turnover was Rs 0.01 crores.

Dr Lalchandani Labs Ltd Medium and Long Term Market Action

The stock price of Dr Lalchandani Labs Ltd is down by 0% over the last one month. Don't forget to check the full stock price history in the table below.

Dr Lalchandani Labs Ltd Fundamentals

Market Cap (Cr): 5.09
Book Value (₹):
Stock P/E:
Revenue (Cr):
Total Debt (Cr):

Face Value (₹):
Roce (%):
ROE (%):
Earnings (Cr):
Promoter’s Holdings (%):

EPS (₹):
Debt to Equity:
Dividend Yield (%):
Cash (Cr):

Dr Lalchandani Labs Ltd Mutual fund holdings and trends

FUND NAME	Quantity	Monthly Change (Qty)

Dr Lalchandani Labs Ltd Shareholding Pattern

Similar Stocks

Company	Price	Market Cap (Cr)	P/E

About Dr Lalchandani Labs Ltd

Data not available.

Dr Lalchandani Labs Ltd FAQ's

What is Share Price of Dr Lalchandani Labs Ltd?

What is the Market Cap of Dr Lalchandani Labs Ltd?

What is PE Ratio of Dr Lalchandani Labs Ltd?

What is PB Ratio of Dr Lalchandani Labs Ltd?

What is the CAGR of Dr Lalchandani Labs Ltd?

How to Buy Dr Lalchandani Labs Ltd Share?

Can I buy Dr Lalchandani Labs Ltd from Samco?

How do I buy Dr Lalchandani Labs Ltd from Samco?

Financials

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

No Data Available

Cons

Low Sustainable RoE
The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
Low Return on Capital Employed
The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
Poor Cash Flow Conversion
The business has very poor cash conversion ratio of only -13.58% of operating earnings getting converted into operating cash flow. This implies that increase in profits has not translated into higher cash flows for the business and incrementally higher investments in working capital which works negatively for shareholders.
Low Interest Coverage
The company has a very low Interest coverage ratio of 0.58 times which implies that a large portion of operating profits are getting attributed to payment of interest to debtholders. This leaves lower earnings and cash flows for equity shareholders which is negative for returns.
Highly Cyclical Industry
The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
Capital Intensive Business
The company operates an extremely capital intensive business with a low Asset turnover ratio of 1.45. A low asset turnover ratio negatively impacts RoE and reduces shareholder returns. Also due to the capital intensive nature of business, growth of the business would need to be funded either via increasing borrowings or diluting shareholders, both of which shall negatively impact shareholder value and returns.
Poor Capital Allocation
The company has disproportionately high amount of assets locked up in working capital, cash and cash equivalents, loans and advances, etc to the extent of 73.58 % of total assets. This reflects poorly on the capital allocation strategy of the management which negatively impacts shareholder returns.
Poor Working Capital Cycle
The company has a very poor working capital cycle of 534 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.
Poor Corporate Governance
The general corporate governance standards of the company are poor which can negatively impact shareholder value and returns.
Negative Margin of Safety
The relative margin of safety of investing in the company is low due to a recent sharp run up in stock prices.

Valuation Analysis

Margin of safety
(09/05/2025)

Margin of Safety Index: Low

100.00%

100.00% People are bullish about Dr Lalchandani Labs Ltd

0.00%

0.00 % People are bearish about Dr Lalchandani Labs Ltd

What is your opinion about this Stock?

Historical Data

Date	Open	High	Low	Close	Volume	Daily Change %